Get started
Minerva Neurosciences IncMinerva Neurosciences IncMinerva Neurosciences Inc

Minerva Neurosciences Inc

No trades
See on Supercharts
OverviewFinancialsNewsIdeasDiscussionsTechnicalsSeasonals

4MNA chart


Full chart

4MNA upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪15.54 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
1.75
Basic EPS (TTM)
1.26 EUR
Net income (FY)
‪1.39 M‬ EUR
Revenue (FY)
0.00 EUR
Shares float
‪5.44 M‬
Beta (1Y)
1.05

Employees


Employees (FY)
8
Change (1Y)
−1 −11.11%
Revenue / Employee (1Y)
0.00 EUR
Net income / Employee (1Y)
‪173.74 K‬ EUR

About Minerva Neurosciences, Inc


Sector
Health Technology
Industry
Pharmaceuticals: Major
CEO
Rémy Henri Luthringer
Website
minervaneurosciences.com
Headquarters
Burlington
Founded
2007
ISIN
US6033802058
FIGI
BBG00VJFWYK5
Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of a portfolio of product candidates to treat central nervous system diseases. It develops Roluperidone for the treatment of negative symptoms in patients with schizophrenia and MIN-301 for the treatment of Parkinson’s disease. The company was founded by Rogerio Vivaldi Coelho and Goeffrey Robin Race on April 23, 2007 and is headquartered in Burlington, MA.

Check out other big names from the same industry as 4MNA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

4MNA news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4MNA is 2.04 EUR — it has decreased by −8.93% in the past 24 hours. Watch Minerva Neurosciences Inc stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange Minerva Neurosciences Inc stocks are traded under the ticker 4MNA.
4MNA stock has risen by 15.25% compared to the previous week, the month change is a 13.97% rise, over the last year Minerva Neurosciences Inc has showed a −15.70% decrease.
4MNA reached its all-time high on Oct 14, 2022 with the price of 14.98 EUR, and its all-time low was 1.08 EUR and was reached on Apr 9, 2025. View more price dynamics on 4MNA chart.
See other stocks reaching their highest and lowest prices.
4MNA stock is 9.80% volatile and has beta coefficient of 1.05. Track Minerva Neurosciences Inc stock price on the chart and check out the list of the most volatile stocks — is Minerva Neurosciences Inc there?
Today Minerva Neurosciences Inc has the market capitalization of ‪15.54 M‬, it has increased by 1.88% over the last week.
Yes, you can track Minerva Neurosciences Inc financials in yearly and quarterly reports right on TradingView.
Minerva Neurosciences Inc is going to release the next earnings report on Nov 10, 2025. Keep track of upcoming events with our Earnings Calendar.
4MNA earnings for the last quarter are −0.37 EUR per share, whereas the estimation was −0.76 EUR resulting in a 52.22% surprise. The estimated earnings for the next quarter are −0.30 EUR per share. See more details about Minerva Neurosciences Inc earnings.
4MNA net income for the last quarter is ‪−2.77 M‬ EUR, while the quarter before that showed ‪−3.47 M‬ EUR of net income which accounts for 20.26% change. Track more Minerva Neurosciences Inc financial stats to get the full picture.
No, 4MNA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 11, 2025, the company has 8 employees. See our rating of the largest employees — is Minerva Neurosciences Inc on this list?
Like other stocks, 4MNA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Minerva Neurosciences Inc stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Minerva Neurosciences Inc technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Minerva Neurosciences Inc stock shows the buy signal. See more of Minerva Neurosciences Inc technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.